Prior Authorization and CPB 1014 Aetna's GLP-1 prior authorization requirements are governed by Clinical Policy Bulletin (CPB) 1014 and administered through CVS Caremark's PA portal
For example, in the largest randomized trial to date (Sleep Apnea Cardiovascular Endpoints, SAVE), there was no difference in the incidence of strokes, heart attacks, composite cardiovascular mortality, or other cardiovascular endpoints between the PAP and usual-care groups [24]
No, lower back pain is not listed as a common or recognized side effect in FDA prescribing information for semaglutide (Ozempic, Wegovy, Rybelsus)
Gastrointestinal adverse reactions can be intensified when semaglutide is taken with other oral medicines or oral medications
All samples were measured in full MS mode using a resolution of 70,000 (AGC target of 3e6 and 64 ms maximum IT)